A process is provided for inhibiting symptoms of intestinal dysbiosis in a subject that includes the oral administration to the subject suffering from intestinal dysbiosis an IgA, IgM, or a combination thereof. When administered in a therapeutic quantity based on the subject characteristics and the ...
Unfortunately, certain factors could cause a breakdown in the balance between the harmful and protective intestinal bacteria. Dysbiosis, also known as dysbacteriosis, can be described as a condition that occurs when there is an imbalance of good to bad bacteria in your body....
Gut microbiome dysbiosis has been demonstrated in subjects with newly diagnosed and chronic inflammatory bowel disease (IBD). In this study we sought to explore longitudinal changes in dysbiosis and ascertain associations between dysbiosis and markers of disease activity and treatment outcome. Methods We...
The intestinal immune response remains the key focus of developing therapies as well. In the past decade, the concept of dysbiosis of the gut microbiome has emerged as a potential pathogenetic focus in IBD, and with this a burgeoning interest in manipulating the microbiome as a means of ...
We used the M-SHIME(), an in vitro simulator for the human intestinal microbial ecosystem, to study the effect of supplementing a single dose of B. pullicaecorum 25-3(T) on lumen- and mucus-associated microbiota of eight individuals. Butyricicoccus pullicaecorum was more abundant in mucus...
(SCFAs), especially butyrate, have been well studied as immunoregulatory molecules4,5. Butyrate is produced by a subset of intestinal bacteria through the fermentation of dietary fibre6. Decreased abundance of butyrate-producing bacteria has been observed in human cohorts of food allergy, asthma, ...
The growth of new bacterial species, reduction of microbial variety or big changes in the ratio between them can lead to a dysbiosis. The relationship between intestinal microbiota and some systemic diseases is seen. The study aimed to present the state of knowledge on FMT in the treatment of ...
Bacteroides vulgatus diminishes colonic microbiota dysbiosis ameliorating lumbar bone loss in ovariectomized mice There is a need to discover additional kinds of intestinal microbiota to supplement the probiotic-treatment of postmenopausal osteoporosis. Increasing evid... SSJ Yuan - 《Bone》 被引量: 0发表...
It has been shown that during the active phase of IBD, there is intestinal flora dysbiosis and decreased species diversity within the organism [21]. CHMF can regulate intestinal flora disorders and maintain the homeostatic balance of intestinal flora [22]. Huang-Lian-Jie-du Decoction, Huangqin ...
The most effective method for the correction of intestinal dysbiosis is the combined use of probiotics and diet with fermentable carbohydrate restriction. The most effective schemes for the use of probiotics have not yet been determined, this question is the subject of further research. The positive...